Key Market Indicators
Dane Antirheumatic Medicine Sales are projected to reach $22 million by 2026. In 2021, the market was worth $30 million, but will decrease by 4.5% year on year. Since 2002, Dane Antirheumatic Medicine Sales have decreased by 4.2% year on year. Austria surpassed Dane in 2021, with $30 million in sales. Germany, Spain and Canada were the second, third and fourth largest markets, respectively.
